Effect of sibutramine on weight maintenance after weight loss: a randomised trial (Q33128832)

2

0 references

Nick Finer

object named as

Nick Finer

3

0 references

Stephan Rössner

6

object named as

Stephan Rössner

0 references

Jannik Hilsted

4

object named as

Jannik Hilsted

0 references

author name string

W Philip T James

1

0 references

Peter Kopelman

5

0 references

Luc F Van Gaal

The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

8

0 references

language of work or name

English

0 references

publication date

December 2000

0 references

published in

The Lancet

0 references

volume

356

0 references

page(s)

2119-2125

0 references

issue

9248

0 references

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

Sibutramine produces dose-related weight loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

A short questionnaire for the measurement of habitual physical activity in epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

Prescription of diabetic diets in the 1980s.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

Analysis of covariance using the rank transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

Lipoprotein heterogeneity and apolipoprotein B metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

Primary prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021

Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903491-7

7 January 2021